Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
432.94quote price arrow up+2.80 (+0.65%)
Volume
108,082
Close
430.14quote price arrow down-24.46 (-5.38%)
Volume
12,775,013
52 week range
63.64 - 497.49
Loading...
  • Open448.08
  • Day High453.61
  • Day Low426.61
  • Prev Close454.60
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low63.64
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap173.626B
  • Shares Out403.65M
  • 10 Day Average Volume13.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change311.74

KEY STATS

  • Open448.08
  • Day High453.61
  • Day Low426.61
  • Prev Close454.60
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low63.64
  • 52 Week Low Date09/24/20
  • Market Cap173.626B
  • Shares Out403.65M
  • 10 Day Average Volume13.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change311.74

RATIOS/PROFITABILITY

  • EPS (TTM)8.01
  • P/E (TTM)53.69
  • Fwd P/E (NTM)9.77
  • EBITDA (MRQ)3.918B
  • ROE (MRQ)72.43%
  • Revenue (MRQ)7.02B
  • Gross Margin (MRQ)84.20%
  • Net Margin (MRQ)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date10/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO1:3001:30
Final Trades: Moderna, Palo Alto Networks, Umpqua Holdings & more

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
333.48-19.51-5.53%
ILMN
Illumina Inc
432.82-0.38-0.09%
REGN
Regeneron Pharmaceuticals Inc
638.90-7.61-1.18%
BIIB
Biogen Inc
291.71-1.49-0.51%
GRFS
Grifols SA
15.29-0.07-0.46%